Back to Ovarian Cancer
NCT01809379
NCT01809379
Who may be able to join
Who might be able to join this trial:
- You have received at least 2 different chemotherapy treatments in the past
- You have ovarian cancer that has come back after previous treatment
- You are able to move around independently (not bedridden)
- You are willing and able to give your formal written agreement to take part in the trial
Who may not be able to join:
- You have a bowel blockage (a condition where the intestines are blocked and cannot pass food or waste through normally)
- You require nutrition to be delivered directly into your bloodstream through a drip (because you are unable to eat or absorb food normally)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 2
Sponsor
Ruhr University of Bochum
Registry
clinicaltrials_gov
Start date
1 February 2013
Est. completion
1 March 2014
Where this trial is recruiting
🇩🇪 Germany
Primary endpoints
Clinical Benefit Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.